VIJAYA2024-07-012024-09-30 VIJAYA2024-07-012024-09-30 VIJAYA2024-07-012024-09-30in-bse-fin:OneOperatingExpenses01Member VIJAYA2024-07-012024-09-30in-bse-fin:FourOperatingExpenses01Member VIJAYA2024-09-30 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 543350 VIJAYA NOTLISTED Vijaya Diagnostic Centre Limited Equity 2024-04-01 2025-03-31 2024-11-07 2024-10-29 INR Lakhs Half yearly 12:00:00 13:30:00 2024-11-07 2024-11-07 true Cash Flow Indirect Not applicable Single segment Diagnostic Services 2024-07-01 2024-09-30 Unaudited Consolidated 1829482000.00 45099000.00 1874581000.00 229881000.00 0.00 0.00 278372000.00 64684000.00 168374000.00 561400000.00 1302711000.00 571870000.00 0.00 571870000.00 128262000.00 22361000.00 150623000.00 0.00 421247000.00 0.00 0.00 0.00 0.00 421247000.00 -342000.00 420905000.00 419364000.00 1883000.00 419022000.00 1883000.00 102622000.00 1 4.09 4.08 0.00 0.00 4.09 4.08 0.00 0.00 0.00 Notes: 1. The above consolidated financial results of Vijaya Diagnostic Centre Limited ( the Company ) and its subsidiaries (the Company and its subsidiaries together referred to as the Group ) have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standards ( Ind AS ) prescribed under Section 133 of the Companies Act, 2013 ('the Act') read with the relevant rules thereunder, other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirements of Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, (as amended). 2. The above consolidated financial results were reviewed by the audit committee and approved by the Board of Directors in their respective meetings held on 07 November 2024. The statutory auditors have carried out limited review of the above results for the quarter and year-to-date ended 30 September 2024. An unmodified report has been issued by them thereon. 3. The Group has one reportable segment (viz. Diagnostic Services) as per the requirements of Ind AS 108 Operating Segments . 4. During the previous year, the Company incurred an amount of Rs. 205 lakhs for the evaluation of various acquisitions towards financial, legal and tax due diligence and for market study on the diagnostic business in target geographies. These expenses had been categorised as exceptional items as these are not incurred in the ordinary course of business of operations of the Company. 5. During the quarter and year-to-date ended 30 September 2024, the Company has issued 24,820 and 2,76,577 equity shares of face value of Re. 1/- each respectively on exercise of employee stock options. 6. The Board of Directors of the Company in their meeting held on 26 June 2024, have considered and approved the proposed Scheme of Amalgamation ('Scheme ) wherein Medinova Diagnostic Services Limited (Subsidiary Company) would merge into the Company with effect from 01 April 2024 (‘the Appointed Date”) under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013, and other rules and regulations framed thereunder ( Scheme ). The aforesaid Scheme is subject to the approval of Stock Exchanges, SEBI, Shareholders and Creditors of the respective companies and National Company Law Tribunal, and such other approvals, permissions, and sanctions of regulatory and other authorities as may be necessary. 7. The Board of Directors of the Company had proposed final dividend of Rs. 1 per equity share (Face value of Rs.1 each) for the year ended 31 March 2024 at their meeting held on 08 May 2024. The same was approved by the shareholders in the Annual General Meeting of the Company held on 06 September 2024 and was paid on 13 September 2024. 8. The results of the Group are available for investors at www.vijayadiagnostic.com, www.nseindia.com and www.bseindia.com Single segment 2024-04-01 2024-09-30 Unaudited Consolidated 3391650000.00 80739000.00 3472389000.00 417458000.00 0.00 0.00 551952000.00 127335000.00 334714000.00 1050041000.00 2481500000.00 990889000.00 0.00 990889000.00 224349000.00 30241000.00 254590000.00 0.00 736299000.00 0.00 0.00 0.00 0.00 736299000.00 -684000.00 735615000.00 732816000.00 3483000.00 732132000.00 3483000.00 102622000.00 1 7.15 7.13 0.00 0.00 7.15 7.13 0.00 0.00 0.00 Other Expenses 561400000.00 Other Expenses 1050041000.00 30661000.00 6635695000.00 175518000.00 0.00 1192049000.00 204375000.00 8805000.00 0.00 0.00 400000.00 0.00 0.00 145759000.00 146159000.00 0.00 144317000.00 8506918000.00 66364000.00 1595735000.00 128261000.00 146708000.00 371245000.00 0.00 389345000.00 2631294000.00 0.00 48408000.00 2746066000.00 0.00 0.00 11252984000.00 102622000.00 7146200000.00 7248822000.00 7279483000.00 0.00 0.00 2687163000.00 2687163000.00 119447000.00 826000.00 0.00 3134000.00 2810570000.00 0.00 380583000.00 647027000.00 1027610000.00 48859000.00 33207000.00 53255000.00 0.00 1162931000.00 0.00 0.00 3973501000.00 11252984000.00 115752000.00 -14537000.00 34136000.00 0.00 -28379000.00 0.00 0.00 38000.00 0.00 51086000.00 0.00 19581000.00 0.00 334714000.00 0.00 0.00 0.00 14438000.00 0.00 0.00 0.00 23049000.00 8500000.00 5703000.00 0.00 -62511000.00 0.00 0.00 0.00 455472000.00 1446361000.00 0.00 0.00 0.00 195003000.00 0.00 1251358000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 400342000.00 3846000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 664446000.00 0.00 0.00 0.00 0.00 0.00 11171000.00 0.00 0.00 0.00 -1049771000.00 0.00 0.00 0.00 0.00 0.00 0.00 38880000.00 0.00 0.00 0.00 213613000.00 0.00 102623000.00 0.00 0.00 0.00 -277356000.00 -75769000.00 0.00 -75769000.00 222477000.00 146708000.00 -457000.00 -914000.00 -115000.00 -230000.00 0.00 0.00